Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Carlson ASI EVIG Alfa Fund, based in Poland, partners with Carlson Ventures International LTD to invest in early-stage technology projects. The fund focuses on research and development (R&D) with a minimum allocation of 80% of resources towards this area. It is part of the Carlson group, which includes Carlson Investments S.A. and EVIG Alfa sp. z o.o.
This fund invests $0 to $275K in pre-seed and seed stage projects, particularly those utilizing artificial intelligence. Key sectors include FinTech, MedTech, Internet of Things (IoT), and CleanTech, with a strong emphasis on projects originating from the Polish academic environment that have potential for global commercialization.
Notable portfolio companies include gSense, a digital health monitoring device; nutrix.tech, a contactless authorization system; enforcemed.pl, a next-generation bionic prosthetic foot; and pelvifly.com, a rehabilitation system for pelvic floor muscles. Other investments include aiseller.space, sensusmind.com, timeqube.com, and hinter.ai.
Email your pitch deck to kontakt@evigalfa.com for consideration.
Yes, Carlson EVIG Alfa typically leads rounds in their investment stages, focusing on early-stage technology projects.
The fund is open to follow-on investments, particularly for projects that demonstrate significant progress and potential for commercialization.
The fund can invest up to PLN 1.1 million (approximately $275K) per project, with a total portfolio of 9 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.